Medicare Enrolled
Dr. David Rawitscher, MD
Cardiovascular Disease · Plano, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rawitscher from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rawitscher?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rawitscher
Dr. David Rawitscher is a cardiovascular disease specialist in Plano, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rawitscher performed 5,795 Medicare services across 3,988 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rawitscher received a total of $167,807 from 52 pharmaceutical and/or device companies across 737 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rawitscher is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 12% volume in TX
$167,807 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,795
Medicare services
Top 12% in TX for cardiovascular disease
3,988
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~290 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
763 | $87 | $238 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
620 | $8 | $17 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
572 | $8 | $41 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
515 | $6 | $30 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
494 | $60 | $186 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
465 | $10 | $51 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
295 | $58 | $168 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
272 | $45 | $215 |
| Evaluation of lower heart chamber assist device Assessment of the function and status of a device that assists the lower chambers of the heart. |
189 | $30 | $142 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
156 | $4 | $26 |
| SPECT nuclear medicine scan, 1 area A nuclear medicine imaging test using a single photon emission computed tomography (SPECT) scan to create detailed images of one specific area of the body. |
113 | $37 | $1,294 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
113 | $2 | $28 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
103 | $121 | $729 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
95 | $19 | $361 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
87 | $49 | $258 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
77 | $130 | $517 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
70 | $5 | $155 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
54 | $52 | $588 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
53 | $326 | $1,599 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
52 | $80 | $393 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
48 | $22 | $109 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
48 | $16 | $84 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
46 | $18 | $98 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
46 | $14 | $65 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 42 | $303 | $846 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
41 | $8 | $96 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
41 | $73 | $207 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
35 | $1,022 | $4,869 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
32 | $111 | $310 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
30 | $48 | $299 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
28 | $20 | $95 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
24 | $16 | $203 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
21 | $28 | $181 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
19 | $14 | $85 |
| 2-day continuous ECG monitoring A continuous electrocardiogram recording that captures heart activity over a 48-hour period. This test helps detect irregular heart rhythms or other cardiac issues that may not appear during a standard, short-term ECG. |
18 | $13 | $105 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
18 | $167 | $858 |
| Heart muscle strain imaging | 18 | $8 | $139 |
| Routine 12-lead electrocardiogram (ECG) A test that records the electrical activity of the heart using at least 12 leads to produce a tracing. |
16 | $4 | $48 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
14 | $76 | $707 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
14 | $8 | $96 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
14 | $137 | $335 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
13 | $17 | $98 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
11 | $79 | $301 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.3% high complexity
15.7% medium
78.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$167,807
Total received (2018-2024)
Avg $23,972/year across 7 years
Top 3% in TX for cardiovascular disease
52
Companies
737
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$141,227 (84.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,727 (9.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,853 (6.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,685
2023
$11,784
2022
$15,526
2021
$2,309
2020
$17,530
2019
$49,261
2018
$64,712
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amarin Pharma Inc.
$44,048
Janssen Pharmaceuticals, Inc
$43,752
Novartis Pharmaceuticals Corporation
$27,896
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$17,839
E.R. Squibb & Sons, L.L.C.
$12,621
Itamar Medical Inc
$9,749
Abbott Laboratories
$3,672
PFIZER INC.
$947
ABIOMED
$689
Celgene Corporation
$600
Alnylam Pharmaceuticals Inc.
$595
Astellas Pharma US Inc
$568
Merck Sharp & Dohme LLC
$539
Novo Nordisk Inc
$491
AstraZeneca Pharmaceuticals LP
$468
Amgen Inc.
$449
Boehringer Ingelheim Pharmaceuticals, Inc.
$416
Terumo Medical Corporation
$350
Inspire Medical Systems, Inc.
$200
Regeneron Healthcare Solutions, Inc.
$196
LivaNova USA, Inc.
$153
Impulse Dynamics (USA) Inc.
$138
GENZYME CORPORATION
$125
Gilead Sciences, Inc.
$123
United Therapeutics Corporation
$112
SANOFI-AVENTIS U.S. LLC
$100
Philips Electronics North America Corporation
$86
Daiichi Sankyo Inc.
$80
HeartFlow, Inc.
$77
Bayer HealthCare Pharmaceuticals Inc.
$72
Janssen Scientific Affairs, LLC
$64
Boston Scientific Corporation
$54
Merck Sharp & Dohme Corporation
$53
Esperion Therapeutics, Inc.
$50
Vifor Pharma, Inc.
$43
Medicure Pharma Inc.
$39
HEARTFLOW, INC.
$35
PROCYRION, INC.
$34
Regeneron Pharmaceuticals, Inc.
$30
Chiesi USA, Inc.
$29
iRhythm Technologies, Inc.
$26
Siemens Medical Solutions USA, Inc.
$25
ARALEZ PHARMACEUTICALS US INC.
$25
Lundbeck LLC
$23
BOSTON SCIENTIFIC CORPORATION
$20
Kiniksa Pharmaceuticals International, plc
$19
Cook Medical LLC
$19
SCPHARMACEUTICALS INC.
$15
Bayer Healthcare Pharmaceuticals Inc.
$15
Tactile Systems Technology Inc
$14
Azurity Pharmaceuticals, Inc.
$14
Edwards Lifesciences Corporation
$11
Top 3 companies account for 68.9% of total payments
Associated products mentioned in payments ›
(5044) MCOT · AMPLATZER AMULET · AMVUTTRA · AORTIX SYSTEM · AVEIR · Adempas · Arcalyst · BRILINTA · Biograph mCT X-4R · CAMZYOS · CARDENE · CARDIOMEMS · Corlanor · ELIQUIS · ENTRESTO · Edarbi · FARXIGA · FFRct · FUROSCIX · Flexitouch Plus · GALLANT · HeartMate · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · HemoSphere · INJECTAFER · INSPIRE · Impella · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · Lexiscan · LifeSPARC System · LifeVest · MULTAQ · NEXLETOL · NEXLIZET · NORTHERA · ONPATTRO · OPTIMIZER · ORENITRAM · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RYBELSUS · Repatha · Rybelsus · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TandemLife · VERQUVO · VYNDAQEL · Vascepa · Veltassa · Verquvo · WAINUA · WATCHMAN · WATCHMAN Access System · WatchPAT · WatchPATONE · XARELTO · ZILVER PTX · ZIO Patch · ZONTIVITY · ZYPITAMAG (pitavastatin)
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for cardiovascular disease in TX.
Equivalent to $2,896 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
284
Per 100K population
25.4
County median income
$117,588
Nearest hospital
CHILDRENS MEDICAL CENTER PLANO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Rawitscher is a clinical cardiology specialist, with above-average Medicare volume (top 12% in TX), with speaking/promotional industry engagement in the top 3% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Rawitscher experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rawitscher performed 763 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rawitscher receive payments from pharmaceutical companies?
Yes. Dr. Rawitscher received a total of $167,807 from 52 companies across 737 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rawitscher's costs compare to other cardiologists in Plano?
Dr. Rawitscher's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rawitscher) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Plano
Browse cardiologists in Plano ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Amarin Pharma Inc. Payments to Doctors
See all physicians who received payments from Amarin Pharma Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology